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Abstract 
The contamination of neurotoxicants in food and the environment has been 
implicated in increases in neuronal disease in advanced countries. Moreover, the 
practical application of engineered nanomaterials or nanoparticles has been promoted 
in medical devises or industrial uses. However, the neurotoxicity of nanomaterials in 
human body remains unclear. Especially, the developing nervous system is highly 
vulnerable to the adverse effects of chemical agents. Therefore, to assess the 
developmental neurotoxicity (DNT) of engineered nanomaterials, a three-dimensional 
neurosphere culture system was developed based on human neural progenitor cells 
(hNPCs).  
In chapter 1, the background of this research was described. PAMAM dendrimer 
nanoparticles, developmental neurotoxicity, human neural progenitor cells and 
three-dimensional neurosphere culture system were introduced. The research 
objective was proposed. 
In chapter 2, to assess DNT of chemicals and nanomaterials, a stable and 
efficient neurospheres culture system was established using human neuronal 
progenitor cells (hNPCs). To optimization of neurosphere assays, spheres were 
cultured of hNPCs on a Laminin 511 (LM511) matrix to elucidate whether 
LM511-enriched basement membrane promotes neurite outgrowth from hNPCs. Cells 
cultured on the LM511 matrix exhibited increased neurite lengths compared with 
those cultured on Laminin 111 (LM111). The results showed that LM511 is an 
 ii 
 
appropriate and stable matrix for neurosphere culturing, and that integration of 
lamina-dense structure provides an ideal surface for neurite outgrowth. It suggests 
that these extracellular microenvironments provide binding sites for neural progenitor 
cells, activating intracellular signaling pathways and promoting sphere formation and 
neurite differentiation. Further, chemicals like benzo[a]pyrene and 5-Azacytidine 
were applied to our established system. Both chemicals significantly inhibited cell 
migration and induced apoptosis.  
In chapter 3, DNT of PAMAM dendrimer nanoparticles was assessed using 
established culture system and was investigated by morphologic approach. 
Biodistribution was investigated using fluorescence-labeled nanomaterials, and 
observed by confocal microscopy. Neurospheres were made as three-dimensional 
structures consisting of neural progenitor cells on free-floating in a well. Proliferation, 
migration, differentiation, and apoptosis, which are basal process of brain 
development, are able to evaluate chemical activity in the 3-D assay. Gene expression 
was evaluated using microarray analysis followed by pathway and network analysis. 
Results showed a reduced number of MAP2-positive cells but not neurite length/cells 
after PAMAM-HN2 exposure, indicating an inhibitory effect on neuronal migration 
but not differentiation. PAMAM-SC (sodium carboxylate) did not affect neurospheres 
at any test concentrations, suggested that natural charged PAMAM-SC will be a 
candidate of drug carrier. Network and pathway analysis  showed Early growth 
response  gene 1 (EGR1), Insulin-like growth factor-binding protein 3 (IGFBP3), 
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Tissue factor pathway inhibitor (TFPI2), and Adrenomedullin (ADM) were key genes 
connected with PAMAM-NH2 dendrimers exposure. The expressions of these genes 
were then confirmed with RT-PCR.   
Collectively, the neurosphere culture system can efficiently and stably be 
established and is a good tool for investigations of the roles of neurotoxins or 
therapeutic agents in neuronal disease. Neurotoxicity testing showed that the exposure 
of neurospheres to PAMAM-HN2  during fetal development affects cell migration 
through Egr1, IGFBP3, TFPI2, and ADM regulated pathways. PAMAM-SC did not 
affect neurospheres at any test concentrations, suggested that natural charged 
PAMAM-SC will be a candidate of drug carrier. 
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Chapter 1 Introduction 
1.1Dendrimer nanoparticles  
Dendrimers are at the forefront of research in nanotechnology because of several 
interesting properties of macromolecular systems, including their precise architecture, 
high uniformity and purity, high loading capacity, and high shear resistance [1]. They 
have shown a great deal of versatility with applications in various areas such as drug 
delivery, medical therapy, electrochemistry, metal recovery, and sensors [2, 3].  
Dendrimers are nano sized particles composed of highly branched polymers. Their 
particle size and surface functional groups can be flexibly controlled when 
synthesized, which is advantageous for applications in electronic, cosmetics, 
automotive, and medical fields. Moreover, dendrimers have a radial structure with a 
large internal free volume, making them suitable as drug carriers [4, 5] and as 
transfection agents for DNA and oligonucleotides [6, 7]. 
 
1.2 Polyamidoamine (PAMAM) dendrimers 
Polyamidoamine (PAMAM) dendrimers are a common type of dendrimers that have 
a radial structure consisting of a 2-carbon ethylenediamine core and functional groups 
on their surfaces. These functionalized surface groups can be easily changed, 
enhancing their wide use for biological applications such as drug [8] or gene delivery [9, 
10]. PAMAM can be synthesized from generation 0 (G0) to G10, the structure of G1 
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and G4 was showed in Fig 1-1. The probability of human exposure to PAMAM 
dendrimers during infancy may increase because of their potential usage. Moreover, 
developing nervous system is highly vulnerable to the adverse effects of chemical 
agents. In these cases, the assessment of the developmental neurotoxicity of PAMAM 
dendrimers is very important. 
Polyamidoamine (PAMAM) dendrimers are a typical type of dendrimers that have 
a radial structure consisting of a multi-carbon ethylenediamine core and functional 
groups on their surfaces. The probability of human exposure to PAMAM dendrimers 
has arisen due to extensive usage including gestational period. PAMAM dendrimers 
have great potential as carriers of anticancer drugs [8] and for gene delivery [9, 10]. In 
addition, dendrimer-based optical/paramagnetic Nano probes can cross the 
blood-brain barrier and be used for imaging of brain tumors [11]. Usage of PAMAM 
dendrimers during pregnancy may trigger transplacental transfer to fetus and infants 
were also exposed to PAMAM dendrimers from environment. In these cases, the 
assessment of the developmental neurotoxicity of PAMAM dendrimers is very 
important. Cytotoxicity studies in vitro have been performed using a human 
keratinocyte cell line [12] and human breast cancer cell lines [13]. The precise 
quantitative absorption and accumulation of nanoparticles was investigated after oral 
ingestion [14]. PAMAM dendrimers were capable of inducing cytokine production via 
the generation of reactive oxygen species, leading to a cytotoxic response in mouse 
macrophage cells [15]. However, the developmental neurotoxicity of PAMAM 
 3 
 
exposure has not been adequately studied.  
The effect of surface modifications to PAMAM dendrimers on their cytotoxicity 
has been studied previously [16, 17], and amine-terminated (NH2) PAMAM dendrimers 
were associated with a higher cytotoxic response. The effect of PAMAM dendrimer 
generation on their cytotoxicity was also investigated using an in vitro experiment that 
examined high-generation (G4, G5, and G6) PAMAM dendrimers [12, 18, 19]. However, 
the wide range of PAMAM generations was not examined yet to elucidate the 
relationship between their generations and cytotoxicity. These studies were further 
conducted at equal molar concentrations, but did not consider increasing the total 
number of surface amines indicating the cytotoxicity with increasing generations.  
 
1.3 Developmental neurotoxicity testing 
Developmental neurotoxicity is any effect of a toxicant on the developing 
nervous system before or after birth that interferes with normal nervous system 
structure or function. The developing nervous system is especially susceptible to 
perturbations because development of the brain continues into the postnatal period 
and limited cell regeneration occurs following damage leading to persistent effects. 
Many chemicals in our environment have not been tested for toxicity to the 
developing brain and nervous system. Accumulating evidence indicates that many 
environmental toxicants are linked to neuronal disease, and some environmental 
toxicants are involved in developmental neurotoxicity (DNT) in humans and rodents 
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[20, 21]. It is well known that in vivo assays give more information about what is really 
happening inside organisms, while estimates based on two-dimensional in vitro 
observations might be very different from the actual in vivo situation. However, 
toxicity testing of chemicals in in vivo experimental studies has led to serious ethical 
concerns. Moreover, in vivo assays are too expensive to acquire batch dose data. 
Therefore, the development of alternative procedures and models is necessary. A 
three-dimensional (3-D) culture system has the advantages of being convenient, 
efficient and similar to the in vivo situation, with improved intercellular interactions, 
and the model is able to replicate basic processes of fetal brain development such as 
proliferation, differentiation and apoptosis [22, 23]. The use of human neurospheres, 
which are a kind of three-dimensional culture system likely to imitate the basic 
processes of brain development, has been a promising approach for DNT testing. The 
developing nervous system is highly vulnerable to the adverse effects of chemical 
agents. Therefore, a neurosphere culture system based on human neural progenitor 
cells (hNPCs) was developed and exposed the neurospheres to chemicals during 
neuronal development to detect DNT. 
 
1.4 Three-dimensional neurosphere 
The neurosphere model 3-D neurosphere assays can simulate development of 
human nervous system and has the following advantages: convenient, efficient, 
similar to the in vivo situation, improves cell interactions, and reflects basic processes 
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of fetal brain development, including proliferation, differentiation, and apoptosis. in 
vitro assays (monolayer culture) are not sensitive and low precision. however, In vivo 
assay is too expensive to acquire batch dose data and has led to serious ethical 
concerns.  
Previous studies have shown that the neurosphere model can be used to test 
developmental neurotoxicity. Differentiating Ntera2/clone D1 (NT2/D1) cell 
neurospheres were exposed to human teratogens such as acrylamide to test their 
developmental neurotoxicity [24]. The effect of valproic acid on neurodevelopment has 
also been studied by regulating gene expression and analyzing gene pathways [25]. In 
addition, the response of two anticonvulsant drugs on gene expression in human 
embryonic stem cells has been analyzed [26]. Neurosphere assays have been used to 
compare human and rat developmental neurotoxicity [27]. In this study, a 3-D 
neurosphere model based on human neural progenitor cells (hNPCs) was used to 
assess the developmental neurotoxicity of PAMAM dendrimers. PAMAM dendrimer 
have the potential to be used us drug carrier, the biodistribution and DNT are 
important. Therefore, the biodistribution of PAMAM dendrimers in the neurosphere 
and the effect of PAMAM dendrimer on neurosphere migration and differentiation 
was investigated. A fluorescence-labeled PAMAM dendrimers was used to investigate 
biodistribution in a 3-D cell culture model by exposing these dendrimers to 3-D 
neurospheres and found a time-dependent biodistribution of the dendrimers. To the 
best of my knowledge, this is the first study that evaluated the developmental 
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neurotoxicity of PAMAM dendrimer nanoparticles in a 3-D cell culture model. 
 
1.5 Human neural progenitor cells 
Human neural stem cells are self-renewing, multipotent cells that generate to 
neurons, astrocytes, and oligodendrocyte lineages through neural progenitor cells 
(NPCs) in vitro. During embryonic development, neural stem cells can generate the 
nervous system. Some neural stem cells in the adult brain can continue to produce 
neurons throughout life.  Human NPCs (hNPCs) can differentiate into different types 
of neuronal cells in vitro (Fig 1-2). It has great potential for treating 
neurodegenerative diseases. Moreover, hNPCs are able to integrate into the host tissue 
and to differentiate into different neuronal subtypes [28, 29]. Therefore, hNPCs have 
been used as a new model system in screening assays for the effects of compounds on 
the development of the nervous system [30-32]. For biological markers of 
neurodevelopmental toxicities, it has been reported that receptor tyrosine kinase-like 
orphan receptor 1 (ROR1) modulates the growth of neurites and their branching 
pattern in hippocampal neurons [33]. The elevated levels of transforming growth factor, 
beta 1 (TGFB1) in ageing and neurodegenerative diseases have also been 
demonstrated [34]. The basic functions of the pro-neural gene, neurogenin 1 
(NEUROG1), have been elucidated; it plays an important role in regulating the 
development of the olfactory system [35], and in neocortical development [36]. In this 
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thesis, hNPCs was differentiate to neurons to culture a neurosphere, chemicals were 
exposure during hNPCs differentiation to simulate chemicals exposure on developing 
human nerve system.   
 
1.6 Innovative point and structure in this thesis 
Innovation points in this thesis are two things that a novel 3-D culture system 
using hNPCs for DNT assessment was developed and DNT of PAMAM dendrimer 
nano-particles were tested using this system. The structure of this thesis shows bellow. 
Chapter 1 Introduction 
In this chapter, the background of this research was introduced, including Human 
neural progenitor cells, Three-dimensional neurosphere, developmental neurotoxicity, 
and Polyamidoamine (PAMAM) dendrimers. Motivation and the structure of this 
study were also addressed.  
Chapter 2 Optimization of neurosphere assays  
In this chapter, neurospheres system formed from human neuronal progenitor 
cells (hNPCs) was established for risk evaluation of chemical exposure. 
Chapter 3 Developmental neurotoxicity testing of nano-particle. 
In this chapter, neurotoxicity of PAMAM dendrimer nano-particle was tested 
using neurospheres system  
Chapter 4 Conclusions and future researches 
In this chapter, the main results are summarized. In particular, the future research 
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points was also directed.  
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Fig. 1-1 Structure of PAMAM dendrimer generation 1 and generation 4.  
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Fig. 1-2 Human neural progenitor cells (hNPCs) can differentiate into different 
types of neuronal cells. 
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Chapter 2 Optimization of neurosphere assays for 
developmental neurotoxicity testing 
2.1 Introduction 
Accumulating evidence indicates that many environmental toxicants are linked 
to neuronal disease, and some environmental toxicants are involved in developmental 
neurotoxicity (DNT) in humans and rodents [20, 21]. It is well known that in vivo assays 
give more information about what is really happening inside organisms, while 
estimates based on two-dimensional in vitro observations might be very different 
from the actual in vivo situation. However, toxicity testing of chemicals in in vivo 
experimental studies has led to serious ethical concerns. Moreover, in vivo assays are 
too expensive to acquire batch dose data. Therefore, the development of alternative 
procedures and models is necessary. A three-dimensional culture system has the 
advantages of being convenient, efficient and similar to the in vivo situation, with 
improved intercellular interactions, and the model is able to replicate basic processes 
of fetal brain development such as proliferation, differentiation and apoptosis [22, 23]. 
The use of human neurospheres, which are a kind of three-dimensional culture system 
likely to imitate the basic processes of brain development, has been a promising 
approach for DNT testing [37, 38]. The developing nervous system is highly vulnerable 
to the adverse effects of chemical agents. Therefore, a hNPCs-based neurosphere 
culture system was developed and chemicals were exposed to the neurospheres during 
the neuronal development to verify whether this system can be used to detect DNT. 
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The basement membrane (BM) is a key component of a neurosphere testing 
model. The three-dimensional system basement membrane provides a scaffold for 
neuronal cell differentiation and is known to regulate adhesion, migration, 
proliferation and differentiation [39]. Poly-L-Ornithine (PLO), a highly positively 
charged amino acid chain, is generally used as a coating reagent to promote cell 
adhesion in culture. PLO alone or in combination with Fibronectin or Laminin-I is 
frequently used to enhance attachment and differentiation of various types of neurons 
and neural stem cells [40, 41]. Laminins synthesized membrane surfaces has a highly 
integrated structure composed of extracellular matrix (ECM) molecules, develop 
niche microenvironment inducing an activation of transcellular membrane signals 
transmission in neuronal cells differentiation. Laminins are the major cell-adhesive 
proteins in the basement membrane, consisting of three subunits termed alpha, beta 
and gamma [42]. In this study, it was attempted to acquire the efficient progenitor cells 
derived neurite outgrow on a substrate that integrates several laminin subunits 
including Laminin 511 (LM511) and Laminin 111 (LM111). LM511 is the most 
widely expressed laminin in the body [43]. The human ES cell membrane has high 
affinity for intact LM511, which is effective for maintaining pluripotency, supporting 
efficient adhesion and expansion of dissociated human pluripotent stem cells [44]. 
LM111 is present in the early embryo and later in certain epithelial cells, but it is a 
rare isoform in vivo [45, 46]. Neurite differentiation protocols enable the creation of 
different subtypes of neurons to study fate decision pathways [47], and have further 
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utility as assay systems to detect adverse effects of toxicity in neuronal development.  
Two chemicals were exposed in the novel culture system to find out whether it 
can be used to evaluate developmental neurotoxicity. Benzo[a]pyrene (BaP), a well 
known carcinogen, is widespread in the environment. Although the neurotoxic effect 
of BaP has not drawn much attention, adverse effects of BaP on learning and memory 
have been reported [48]. Neuronal apoptosis plays a major role in BaP-induced 
neurotoxicity [49]. 5-Azacytidine (5AZ) is a potent inhibitor of DNA methylation [50]. 
It has been reported that 5AZ induces toxicity in PC12 cells and in rat brain, however, 
no neurotoxicity has been found [51, 52]. 
 
2.2 Materials and methods 
2.2.1 Chemicals 
L-glutamine, Poly-L-ornithine and laminin from engelbreth-holm-swarm 
(LM111) were provided by Sigma-Aldrich (Tokyo, Japan). Human recombinant 
laminin (LM511) was obtained from BioLamina AB (Stockholm, Sweden). 
Benzo(a)pyrene and 5-Azacytidine was bought from Schell Chemical (Co, New York, 
N. Y). 
2.2.2 hNPC sphere formation and neural cell differentiation on the extracellular 
matrix 
The human neuronal progenitor cells (hNPCs), derived from H9 human 
embryonic stem cells, were obtained from Chemicon-Millipore (ENStem Human 
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Neural Progenitor Expansion Kit; Norcross, GA). For hNPC proliferation prior to the 
neural progenitor sphere (NPS) formation, preparations were incubated in 
poly-L-ornithine/LM111-coated 60-mm Petri dishes with NEM medium (ENStem-A 
Neural Expansion Medium(EMD Millipore, Japan) with Glutamine and FGF-2 
supplement solution) and then hNPCs were seeded at a density of 2 × 106 cells/dish 
and incubated for 4 days. Preparations were then dissociated with accutase 
dissociation solution (ICT, FUAT104). Procedures of neurosphere culturing was show 
in Fig 2-1, sphere were formed from day0 to day 5, NPS formation was conducted in 
Nunc low cell binding 96-well plates (Thermo Fisher Scientific Inc., Waltham, MA) 
with a density of 6 × 103 cells/well in NEM medium. In the final step, NPS were 
transferred and seeded to 48-well plates in which the wells were coated with LM511 
(BioLamina AB), a mixture of LM511 and LM111 (LM511+LM111), or mixture of 
poly-L-ornithine, LM111 and LM511 (PLO/LM511+LM111), or a combination of 
poly-L-ornithine and LM111 (PLO/LM111), separately. The wells contained 
Neurobasal (Gibco,Japan) medium containing 5 units/ml penicillin with 5 μg/ml 
streptomycin and Gibco supplement B27 (1/50), Glutamax-1(1/100, Gibco), N2 
(1/100, WAKO,Japan) and BDNF (1/1000, Gibco). The spheres were continuously 
cultured for at least 5 days to induce mature neural cells. 
 2.2.3 Immunohistochemistry staining 
Neurospheres were fixed with 4% paraformaldehyde for 15 min at RT, and 
permeabilized by incubation for 30 min in 0.1% Triton X-100 (SigmaAldrich, 
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Japan)PBS. After blocking non-specific binding with 0.1% bovine serum albumin 
(BSA) in PBS, the fixed neurospheres were incubated with primary antibodies 
(MAP2 monoclonal, SigmaAldrich, Japan) overnight at 4°C, and then for 1 h at 37 °C 
with goat anti-mouse IgG antibodies conjugated to Alexa Fluor 568 (orange 
fluorescent dye, Invitrogen, Life Technologies, USA) or Alexa Fluor 488 (green 
fluorescent dye, Invitrogen, Life Technologies). The neurospheres were then 
incubated with Hoechst 33342 work solution (Molecular Probes, Life Technologies) 
for 15 min at RT. The staining was visualized with a fluorescent microscope 
(Olympus IX70, Olympus Corporation, Tokyo, Japan).  
2.2.4 Image analysis for neurite outgrowth 
Sphere area and neurite migration were investigated. Images for each 
neurosphere were acquired with a 10 x lens, and radii of the core (R1) and sphere (R2) 
were measured using Image J.  Corona areas were calculated (area of R2 minus area 
of R1). For determination of neurite length/cell, the IN Cell Analyzer 1000 (GE 
Healthcare, Japan) was used to automatically acquire fluorescent images. 20 images 
obtained with a 10 x lens were used to analyze neurite length. Cell images were 
analyzed using IN Cell Developer box (GE Healthcare). Cellular nuclei were first 
segmented and counted using the Hoechst channel. The neuron cell bodies were then 
segmented and their associated neurites were identified using the MAP2 channel. 
Neurite length was identified for each cell body and neurite length/cell was 
calculated.  
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2.3 Results  
2.3.1 Neurosphere formation and differentiation 
To develop a neurosphere differentiation culture system, it was utilized a 
three-dimensional embryoid aggregate protocol to examine neurosphere formation 
and differentiation using various types of coating matrices. Fig. 2-2 A is the timeline 
schematic for this protocol, in which neuronal progenitor sphere(NPS) were formed 
by Day 5 and neural maturity was induced by Day 10. Neurospheres and expanding 
single layer hNPC coronas were formed on all types of membrane-coated surfaces by 
Day 8. The expanded corona area of neurosphere was observed in PLO/LM111 
coated surfaces, but the neurosphere central area was weak and not well attached on 
coating surfaces at Day 10 (Fig. 2-2B). Comparing the three other types of coating 
membranes at Day 10, significant neurosphere expanding corona areas were 
observed in the PLO/LM511+111 coated surface (Fig. 2-2B). The neurosphere 
expanding corona areas were significantly increased in PLO/LM511+111 surface on 
Day 10 compared with other coating systems (Fig. 2-3). However, the corona areas 
were too expanded and not stable, suggesting that the PLO/LM511+111 surface is 
not suitable for neurotoxicity testing. For further investigation of the expanding 
corona region, the neurite length/cell were analyzed, however, no significant 
differences were found for neurite length/cell (Fig. 2-5).  
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2.3.2 Benzo[a]pyrene and 5-Azacytidine exposure 
To investigate whether the LM511 coating is appropriate for assessment of 
neurotoxicity of chemicals, neurospheres on LM511-coated surface were exposed to 
benzo[a]pyrene (BaP) and 5-Azacytidine (5AZ) from Day 2 to Day 5 (Fig. 2-6A). 
BaP at a concentration of 10 µg/ml significantly inhibited expanding corona areas 
(Fig. 2-7A). However, BaP did not affect neurite length/cell at any test concentrations 
(Fig. 2-7 B). 5AZ at a concentration of 0.3 µg/ml significantly inhibited expanding 
corona areas, while no significant differences from controls were found for lower 
concentrations (Fig. 2-9A). However, no significant changes were found for neurite 
length/cell at test concentrations (Fig. 2-9B).  
 
2.4 Discussion and summary  
The aim of this section was to determine an optimal basement membrane culture 
system and establish a neurosphere model to detect developmental neurotoxicity. A 
novel, efficient three-dimensional culture system for neurosphere formation and 
neuronal differentiation was developed with a combination of neurosphere formation 
on U-bottom plates and differentiation on the extracellular matrix.  
Several kinds of coating system were tested. The neurosphere expanding corona 
areas were significantly increased on PLO/LM511+111 surface on Day 10. The 
extended neuron was too much compare with other coating system. Moreover, the 
standard deviation value was high, suggesting that the PLO/LM511+111 surface is 
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not as stable as the LM511 and is not suitable for neurotoxicity testing. The results 
suggest that neurospheres can be maintained and appropriately differentiated when 
cultured using a LM511 or LM511+LM111 coating system. The LM511-coated 
surface system is more efficient and easier to operate than LM511+LM111 coating 
system, therefore it is suggested that LM511 is the best coating system. Culture 
systems using LM511 have been reported previously [53]. hES/iPSCs 2-D culture 
system were well established under LM511 coating surface.  Basement membrane 
components play an important role in supporting the regional-specific differentiation 
of embryonic stem cells into hepatic endoderm. Using an HEK293 cell line 
(rLM10-293 cells) stably expressing LM511, embryonic stem cells could be induced 
to differentiate into definitive endoderm and subsequently into pancreatic lineages [54]. 
Instead of using cell-generated LM511, a commercially produced LM511 was used to 
establish a culture system. An efficient three-dimensional culture system for NS 
formation and neuron differentiation was developed. This novel NS culture system 
was used to assess neurotoxicity in previous study [55].  
It has been shown recently that Benzo[a]pyrene may induce neurotoxicity [56, 57].  
However, 5AZ can only induce acute toxicity in the nervous system via apoptosis [50, 
58, 59]. Therefore, two chemicals were used to evaluate the novel model to determine 
whether it can assess neurotoxicity. It was found that both chemicals inhibit corona 
areas of neurospheres, suggesting that both chemicals may influence cell migration. 
BaP induced decreases of neurite length/cell at concentrations of 1 µg/ml and 10 
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µg/ml However, 5AZ induced significant increases in neurite length/cell at a 
concentration of 0.3 µg/ml. It is suggested that BaP but not 5AZ induces 
neurotoxicity by inhibiting neurite differentiation. The increased neurite length/cell 
may because of the decreased cell number.  
The results revealed that a LM111 coating system cannot support the 
neurospheres for long enough. A PLO/LM511+LM111 coating system showed the 
best attachment, however, the neurospheres that formed were too extended to make a 
stable system. The LM511 and LM511+LM111 coating systems showed similar 
performance, but LM511 strongly supported neurosphere culture for long periods. 
hNPCs showed the ability to differentiate to neuronal cells and neurites were well 
developed on a LM511-coated surface.. Therefore, it is suggested that LM511 single 
coating is best for establishing a stable and efficient culture system. Both BaP and 
5AZ inhibited cell migration. BaP, but not 5AZ, inhibited neuronal differentiation. It 
is suggested that this neurosphere model can be used to evaluate developmental 
neurotoxicity. Neuron migration can be analyzed by measurement of expanding 
corona areas. Neurite differentiation can be quantified by measuring neurite 
length/cell. 
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Fig. 2-1 Procedures of neurosphere culturing. Spheres were formed from day 0 to day 
5 in 96-well plates with round bottoms, and then transferred and seeded to 48-well 
plates in which the wells were coated with BM, separately. Further, spheres were 
continuously cultured for another 5 days at least to induce mature neural cells. 
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Fig. 2-2 Culture schedules (A) and photographs (B) of sphere formation, 
differentiation and migration. Sphere formation was conducted as described as Fig. 
2-1. Images of neurospheres shows Spheres, which were cultured with different 
matrices on Day 8 and Day 10. 
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Fig. 2-3  Quantitative analysis of expanding corona area neurospheres (R2-R1), 
examined by fluorescence microscopy. Data are expressed as mean ± SD for three 
independent experiments. *P < 0.05 was considered to be statistically significant 
differences between  groups using  ANOVA followed by tukey. 
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Fig. 2-4 Immunofluorescence of MAP2-positive hNPCs at expanding corona on 
LM511-coated plates, LM511+LM111-coated plates and PLO/LM511+LM111-coated 
plates. Cells were stained with hoechst33342 (blue) and Alexa 488-conjugated 
anti-MAP2 (green).  
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Fig. 2-5 Typical outgrowth of neurosphere. Quantitative analysis of neurite length / 
MAP2-positive cell and nuclei member counting. Data are expressed as mean ± SD 
for three independent experiments. Significant differences between  groups using  
ANOVA followed by tukey.  
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Fig. 2-6 Schematic of chemical exposure of neurospheres (A). hNPC were incubated 
with  chemicals from Day 2 to Day 5 in 96-well plates with round bottoms. To 
compare four different coating membrane in day 10, cells were stained with 
hoechst33342 (blue) and MAP2 (Alexa 568, red). Typical outgrowth of neurosphere 
exposed to BaP, four parallel spheres were tested for each concentration (B). 
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Fig. 2-7 Quantitative analysis of exposed to BaP at concentrations of 0.1- 10 µg/ml 
for corona area (A). Quantitative analysis for neurite length / MAP2-positive cell and 
nuclei member counting (B). Data are expressed as the percentage of the control ± SD 
for three independent experiments. *P < 0.05 was considered to be statistically 
significant differences between the treatment group and the vehicle control using  
ANOVA followed by dunnett's post hoc test. 
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Fig. 2-8 Typical outgrowth of neurosphere exposed to 5AZ. Cells were stained with 
MAP2 (Alexa 568, red). Four parallel spheres were tested for each concentration. 
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Fig. 2-9  Quantitative analysis of exposed to 5AZ at concentrations of 0.03-0.3 
µg/ml for corona area. (A) Quantitative analysis for neurite length / MAP2-positive 
cell and nuclei member counting. (B) Data are expressed as the percentage of the 
control ± SD for three independent experiments. ***P < 0.001 were considered to be 
statistically significant differences between the treatment group and the vehicle 
control using ANOVA followed by dunnett's post hoc test. 
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Chapter 3 Effects of PAMAM dendrimers 
nanoparticles on neurosphere 
3.1 Introduction 
Polyamidoamine (PAMAM) dendrimers nanoparticles are a common type of 
dendrimers that have a radial structure consisting of a 2-carbon ethylenediamine core 
and functional groups on their surfaces. These functionalized surface groups can be 
easily changed, enhancing their wide use for biological applications such as drug [8] or 
gene delivery [9, 10]. PAMAM dendrimer can be synthesized from generation 0 (G0) to 
generation 10 (G10). The size of PAMAM dendrimers were increased with increasing 
generation. The probability of human exposure to PAMAM dendrimers during 
infancy may increase because of their potential usage, and developing nervous system 
is highly vulnerable to the adverse effects of chemical agents. Moreover, in order to 
use PAMAM dendrimers as drug carrier to treat brain disease, PAMAM need to reach 
parenchyma of brain. In these cases, the assessment of the developmental 
neurotoxicity of PAMAM dendrimers is very important. In this section, DNT of two 
kings of generation 4 PAMAM dendrimers were assessed: positive charged 
PAMAM-NH2 and natural charged PAMAM-SC (sodium carboxylate). 
To assess PAMAM dendrimer toxicity on human brain after intracerebroventricular 
injection, firstly, in vitro study is needed to study neurotoxicity of PAMAM 
dendrimers on neuron cells. Previous studies have shown that the embryonic stem 
cells model can be used to test developmental neurotoxicity. The effect of valproic 
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acid on neurodevelopment has also been studied by regulating gene expression and 
analyzing gene pathways. However, most of agents cannot be identified with certainty. 
This is because 2-D models do not reflects basic processes of fetal brain development. 
Therefore, 3-D neurosphere model should be used. The neurosphere model has the 
following advantages: convenient, efficient, similar to the in vivo situation, improves 
cell interactions, and reflects basic processes of fetal brain development, including 
proliferation, differentiation, and apoptosis. Differentiating Ntera2/clone D1 (NT2/D1) 
cell neurospheres were exposed to human teratogens such as acrylamide to test their 
developmental neurotoxicity [24]. The effect of valproic acid on neurodevelopment has 
also been studied by regulating gene expression and analyzing gene pathways [25]. In 
addition, the response of two anticonvulsant drugs on gene expression in human 
embryonic stem cells has been analyzed [26]. Neurosphere assays have been used to 
compare human and rat developmental neurotoxicity [27]. In this section, the 
neurosphere model was used to assess the neurotoxicity of PAMAM dendrimers. The 
migrated cell from neurosphere core was investigated, It was also investigated the 
biodistribution of PAMAM dendrimers in the neurosphere and the effect of PAMAM 
dendrimer on neurosphere. A fluorescence-labeled PAMAM dendrimers was used to 
investigate biodistribution in a 3-D cell culture model by exposing these dendrimers 
to 3-D neurospheres and found a time-dependent biodistribution of the dendrimers. To 
the best of my knowledge, this is the first study that evaluated the developmental 
neurotoxicity of PAMAM dendrimer nanoparticles in a 3-D cell culture model. 
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3.2 Materials and methods 
3.2.1 Dendrimers and  test chemicals  
  PAMAM (ethylenediamine core, generation 4.0; Cat. No. 664049-1KT) 10 wt.% 
methanol solution and PAMAM G4-SC which was modified with sodium carboxylate 
surface groups (10 wt. % in methanol, 412430-2.5G) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). PAMAM was conjugated with an Alexa546 
fluorophore to prepare infrared-labeled PAMAM dendrimers. Conjugation has been 
synthesized via an amide bond between the primary amine of the dendrimer and the 
N-hydroxysuccinimide-activated carboxyl of the fluorophore. 20 mg of PAMAM G4 
stock solution was combined with 0.1 M Alexa Fluor 488 or Alexa Fluor 546 
carboxylic acid, succinimidyl ester (Invitrogen., Eugene, Oregon, USA) at pH 8.3. 
The reaction was allowed to proceed under stirring for 3 hours in RT. The product was 
purified using a Slide-A-Lyzer Dialtsis Cassette (Thermo Scientific., USA) with 3500 
Dalton cut off to remove free fluorophore.  
3.2.2 Reagents for cell-based assays 
  Neural expansion media (NEM) were obtained from ENStem-A. Neurobasal 
medium and Glutamax were purchased from Life Technologies (Gibco; USA). hNPCs 
derived from H9 human embryonic stem cells were obtained from 
Chemicon-Millipore (ENStem Human Neural Progenitor Expansion Kit; Norcross, 
GA, USA).  
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3.2.3 Neurosphere formation and Incorporation of Alexa-labeled PAMAM  
hNPCs were cultured in NEM supplemented with 0.05% b-FGF and 1% 
L-glutamine on poly-ornithine-coated and LM111-coated dishes. On day 0 (d0), the 
cells were transferred to 96-well round bottom plates (Nunc, Falcon) at a density of 
6,000 cells per well to allow neurosphere formation, this 3-D culture system has been 
established in previous study (Zeng et al., 2015).   
Alexa546-labeled PAMAM dendrimers at a concentration of 10 μg/ml were 
incubated with neurospheres in 96-well round bottom plates at day 2. The spheres 
were transferred to a LM511-coated glass bottom dish for observation at day 3, day 4, 
and day 5. Microphotographs showing the incorporation of Alexa546-labeled 
PAMAM dendrimers were obtained using an Olympus LV1200 High-Performance 
Laser Scanning Microscope (Olympus Optical, Japan). Images for illustration were 
obtained using 10× and 20× objectives. The 3-D images were created by FV10-ASW 
software (Olympus Optical, Japan) using 7 images per stack. The thickness for each 
stack was 3μm. 
3.2.4 Immunofluorescence and morphological analysis 
To investigate neurosphere proliferation, migration and differentiation, on day 2 
(d2), 3 doses of PAMAM dendrimers (1 μg/ml, 3μg/ml and 10 μg/ml) were exposed 
for 72 h in NEM and NDM, respectively.  
On day 5 (d5), neurospheres were transferred in NEM (ENStem-A) 
supplemented with 0.05% b-FGF and 1% L-glutamine (Sigma-Aldrich, St. Louis, MO, 
 33 
 
US) on poly-ornithine-coated (Sigma-Aldrich, St. Louis, MO, US) and LM111-coated 
(Sigma-Aldrich, St. Louis, MO, US) 48-well plates. At day 7, Plus EdU Alexa Fluor 
imaging kits (Thermo fisher sentific, Tokyo, Japan) was used to label newly 
synthesized DNA in hNPCs for 24 h. At day 8, cells were then treated with 2 g/ml of 
Hoechst 33342 solution for 15 min at room temperature to label all cell nuclei. 
Immunofluorescence images were acquired using FV1200 (Olympus, Tokyo, Japan). 
Sphere area was investigated using Image J. Sphere was identified manually and area 
was calculated by software.  
To investigate neurosphere differentiation, the neurospheres were gently 
transferred to a 48-well plate that was pre-coated with LM511 and contained neural 
differentiation media (neurobasal medium, NDM), supplemented with 1× B27, 1× N2, 
and 10 ng/ml BDNF (Invitrogen, Carlsbad, CA). NDM was changed every 3 days. 
Immunostaining was performed on day 10 (d10). Neurospheres were fixed using 4% 
paraformaldehyde for 15 min and then treated with 0.1% TritonX-100 for 30 min. 
After incubating with 1% BSA-PBS for 30 min at RT, cells were treated with primary 
antibodies [mouse anti-microtubule-associated protein 2 (MAP2; 1:200 dilution; 
Sigma–Aldrich)] overnight at 4C. After washing with PBS, the cells were incubated 
with secondary antibodies (Alexa Fluor 488 donkey anti-mouse lgG; 1:1,000 dilution) 
for 1 h at RT. Following this, the cells were treated with 2 g/ml Hoechst 33342 
solution for 15 min at RT. Neurite length per cell and nuclei number were analyzed 
and calculated using an InCell analyzer 1000 (GE Healthcare, Tokyo, Japan). Images 
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were obtained using a 10x objective; furthermore, 9 images were acquired for each 
well. Sphere area and neurite migrations were investigated using Image J. 
3.2.5 Microarray and bioinformatics analysis 
On day 2 (d2), neurospheres for microarray were treated with PAMAM 
dendrimer-NH2 (0.3 μg/ml) for 72 h. Four neurospheres from different experimental 
groups were pooled together separately. RNAs were isolated from each group at day 5. 
To detect changes in gene expression in neurospheres after PAMAM dendrimer 
exposure, microarray analyses were performed on two RNAs samples using a 
microarray (Sureprint G3 Human GE 8 × 60K Ver.2.0 1color 4; Agilent Technologies 
Inc., Santa Clara, CA, USA). The arrays were hybridized and scanned in accordance 
with the manufacturer’s directions at the facility of Hokkaido System Science Co., 
Ltd. (Sapporo, Japan). The raw data were normalized and filtered by expression to the 
cut-off low values and then filtered by flag tag to remove entities that were not 
detected using GeneSpring GX12.10 software (Agilent Technologies). The microarray 
data were submitted to Gene Expression Omnibus (GEO) and registered as 
GSE65875 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse65875). Genes 
with fold changes in log 2 expression values of >1.5 or ≤1.5 from each group were 
selected and combined to generate a common entity list. 32 Genes from the 
commonly responsive list were analyzed using Single Experiment Analysis (SEA) of 
GeneSpring to find matching genes in the WikiPathways. Matched gene entities from 
the top five pathways were selected; these 12 genes were then analyzed using the 
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natural language processing (NLP) network analyses of GeneSpring to identify extend 
interactions. 
3.2.6 Quantitative gene expression analysis 
In order to confirm gene expression, On day 2 (d2), neurospheres for RT-PCR 
were treated with PAMAM dendrimer-NH2 (0.3 μg/ml, 1 μg/ml 3 μg/ml) for 72 h. 
RNAs were isolated from each group at day 5. RNAs was extracted and purified using 
the RNeasy Micro kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
protocol. The RNA quality and quantity were then examined using 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara, CA, USA). High-Capacity RNA-to-cDNA kit 
(Applied Biosystems, Foster, California, USA) was used for RNA reverse 
transcription. Power SYBR green PCR master mix (Applied Biosystems, Foster, 
California, USA) and a MicroAmp Optical 96-Well Reaction Plate were used for 
real-time PCR with the 7000 Sequence Detection System (ABI PRISM, 
Foster City, USA). The following primer sets were used: TFPI2, 
5′-TTCAGACTGAGGCTTCTATGGG-3′ (forward) and 
5′-GTAAAACGACGGCCAGTTGAAGATACAGCTACCGTCTACTGC-3′ (reverse); 
Spry1, 5′-GTAAAACGACGGCCAGTGCGGTTTAGGCAATTTGTGATT-3′ 
(forward) and 5′-CCCTGGCATTACTTGGGAGT-3′ (reverse); EGR2, 5′- 
AGCTTTGCTCCCGTCTCTG-3′ (forward) and 5′-AGCTGGCACCAGGGTACT-3′ 
(reverse); IGFBP3, 5′-AGAGCACAGATACCCAGAACT-3′ (forward) and 
5′-TGAGGAACTTCAGGTGATTCAGT-3′ (reverse); ADM, 
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5′-ACTTCGGAGTTTTGCCATTG-3′ (forward) and 
5′-CTCTTCCCACGACTCAGAGC-3′ (reverse); KCNJ2, 
5′-TGTTTTCCAAAGCAGAAGCA-3′ (forward) and 
5′-CCCATCTTGACCAGTACCGT-3′ (reverse);    
3.2.7 Statistical analysis 
Quantitative data were expressed as the percentage of the control  SD of at least 
three independent experiments. Analyses were performed using SPSS statistics v.19 
(IBM, Tokyo, Japan). Statistical significance was determined by one-way ANOVA, 
followed by the Dunnett’s tests for pairwise comparisons. Differences were 
considered statistically significant when P < 0.05.  
 
3.3 Results  
3.3.1 Neurosphere assay for assessing test chemicals 
This culture system was established in last section, for neurosphere formation, 
neurospheres were cultured in uncoated round bottom plate from day 0 to day 2 (Fig. 
3-1C). Human progenitor cells formed spheres during 3-D cell culture, and exposure 
to PAMAM dendrimers was conducted for 3 days after sphere formation from day 2 
to day 5. After transfer to the NDM media, spheres grew and neurite cells migrated. 
After plating for adhesion, polarized individual cells migrated outward from the 
spherical center after 24 h. At day 5, the cell body size and projection length increased 
(Fig. 3-1D); at 10 days, cellular projections increased not only in size but also in 
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density (Fig. 3-1E). Individual cells displayed multiple neurite outgrowths and 
dendritic spines, which are typical characteristics of both immature and mature 
neuronal phenotype (Fig. 3-1F).  
3.3.2 Incorporation of PAMAM dendrimers in neurospheres 
To examine the bioincorporation of PAMAM dendrimers in neurospheres, 
Alexa-PAMAM conjugates were incubated with neurospheres for 3 days. Alexa 
488-conjugates was used in sphere assay, but not the Alexa546 for intra-sphere 
distribution because fluorescent activity of Alexa 488 is weaker than it of Alexa. It 
was hard to get clear picture for Alexa 488 distributions because sphere is thickness. 
To confirm that free fluorescent agent are not able to uptake in neurospheres, a group 
of neurospheres were treated with PAMAM dendrimers for 3 days and then treated for 
72 h with the fluorescent agent only. No fluorescent signal was observed in the 
neurospheres. For Alexa-PAMAM conjugate-treated group, Alexa-PAMAM conjugate 
was incubated with neurospheres at day 2 (d2). Cross-section images of neuropheres 
were shown in Fig. 3-2A，B and C. The 3-D images were generated using 
cross-section images and 3-D images were reversed to show the center of 
neurospheres. (Fig. 3-2D, E, F).The Alexa-546 fluorescence signal was only observed 
on the surface of neurospheres at day 3 (Fig. 3-2A, D), and an increasing number of 
Alexa-PAMAM conjugates was observed within the neurospheres at day4 (Fig. 3-2B, 
E) and day 5 (Fig. 3-2 C, F). The results showed a time dependent bio distribution of 
PAMAM dendrimer and serve as evidence that Alexa-PAMAM was located in the 
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center of neurospheres after 3 days of exposure.  
3.3.3 Effect of PAMAM dendrimers on proliferation and migration of neurospheres 
To study the effect of PAMAM dendrimers on proliferation, newly synthesized 
DNA of hNPCs was labeled with a bright fluorescently (EdU), nuclei was labeled 
with Hoechst 33342. The typical images (4×) of PAMAM dendrimers are shown in 
Figure 3-3(A–L). To quantify the effects of the dendrimers, neurosphere area was 
measured using Image J. The mean area of the neurosphere area decreased 
comparison with that observed in the controls (Fig. 3-4). Proliferation of cells in the 
flare areas which is shifted from the neurosphere core was investigated. These cells 
were considered as newly generated cells after PAMAM exposure. The EdU positive 
cell number decreased in flare area, suggest that PAMAM dendrimer inhibit migration 
but also cell proliferation. 
3.3.4 Effect of PAMAM dendrimers on neuronal differentiation of neurospheres  
To study the developmental neurotoxicity of PAMAM dendrimers, the neurite of 
neurospheres were immunohistochemically stained with anti-MAP2 protein antibody 
on day 10. The typical effects of PAMAM dendrimers are shown in Figure 3-5 (A–I). 
To quantify the effects of the dendrimers, the central core sizes of the neurosphere 
without flare areas and the flare areas that indicated cell migrations and cell 
proliferations were measured using Image J software. PAMAM dendrimer-NH2 
dose-dependently and significantly inhibited cell migration and cell proliferation, the 
mean area of the extended neuron decreased comparison with that observed in the 
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controls (Fig. 3-6). Alexa-PAMAM conjugates at a concentration of 10 μg/ml 
inhibited cell migration; the extent of inhibition was similar to that observed using 
PAMAM-NH2 dendrimers (Fig. 3-5I); however, Alexa-PAMAM conjugates did not 
affect migration or differentiation, whereas PAMAM-NH2 dendrimers did at a 
concentration of 1 μg/ml (Fig. 3-5H ), suggest that surface group (NH2) is important 
to understand PAMAM toxicity. PAMAM-SC did not exert similar effects on 
MAP2-positive neurospheres at any test concentration (Fig. 3-5E, F). 
The effects of PAMAM dendrimers on neurite length per cell and nuclei number 
that migrated from neural spheres were investigated (Fig. 3-7) and quantitatively 
determined. However, the dendrimers did not inhibit neurite length per cell at any 
concentration tested in the present study. In contrast, neurite length per cell 
significantly increased at concentration of 10 μg/ml (Fig. 3-8A), and this may be 
because of small cell density lead to long neurite length, a decreased number of live 
cells was observed after PAMAM- NH2 exposure. (Fig. 3-8B).  
3.3.5 Gene expression profiling in PAMAM dendrimer-exposed spheres by 
microarray analyses and RT-PCR 
The expression of 50,739 genes was detected by microarray analysis after 
PAMAM dendrimer exposure. Genes those are not detected and with low expression 
value were filtered, leaving behind 25,622 genes. With fold changes in log2 expression 
values of >1.5 or ≤1.5, 289 and 171 of the entities were filtered from two independent 
experiments, respectively. Thirty-two of these genes were responsive in both 
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experiments.. These 32 genes were then analyzed by SEA to find matching genes in 
WikiPathways. Pathway analysis showed that direct interactions, Network targets and 
regulators pathway, and Hs_Adipogenesis were the most matched pathways (Table 1). 
The matched gene expressions are shown in Table 2. Most of the matched genes, 
except CYP26A1, were down regulated. It was then analyzed how the genes interact 
with each other in natural language processing method. The result revealed three 
independent networks. Early growth response  gene 1 (EGR1) (Fig. 3-9A), 
insulin-like growth factor-binding protein 3 (IGFBP3) (Fig. 3-9B), tissue factor 
pathway inhibitor (TFPI2), and adrenomedullin (ADM) (Fig. 3-9C) were the key node 
in each network. Therefore, the expression of key genes (TFPI, SPRY2, IGFBP3, 
KCNJ2, ADM and EGR1) were then confirmed using RT-PCR (Fig. 3-10). All 
selected genes were down regulated from concentration 1 μg/ml except EGR1. 
 
3.4 Discussion and Summary  
In order to define the migration and differentiation on human during nervous 
development after intracerebroventricular injection of PAMAM dendrimer, a hNPCs 
based neurosphere system was performed. To the best of my knowledge, this is the 
first study to profile the gene response of neurospheres to PAMAM dendrimer 
exposure using microarray analysis. This showed the mechanism of cationic PAMAM 
dendrimers-NH2 affect neurosphere.  
A few studies have reported the effects following exposure to PAMAM 
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dendrimers. For example, an in vitro study suggested that PAMAM induced the 
aggregation of human platelets in plasma [60]. It has recently been suggested that the 
exposure of PAMAM dendrimers to animals induces surface chemistry-dependent 
central neural cytotoxicity, whereas penetration into living neurons was observed after 
intraparenchymal or intraventricular injection of these molecular complexes [61]. In 
my previous study, using monolayer culture assay, G4 PAMAM-NH2 did not inhibited 
cell proliferation at 1ug/ml. However, using neurospheres culture system in this part, 
G4 PAMAM-NH2 significantly inhibited cell proliferation at 1ug/ml. suggested that 
neurosphere culturesystem is sensitive compare with 2-D monolayer culture system. 
In the present study, hNPCs was used to study the effects of G4 PAMAM 
dendrimers on neuronal differentiation. hNPCs were exposed to various 
concentrations of dendrimers for 72 h and then allowed to differentiate for additional 
5 days. A surface type-dependent toxicity was observed. Cationic NH2 but not anionic 
SC surface functional group dendrimers induced migration but not differentiation of 
neurospheres. Dendrimers were observed in neurospheres after 2 days of exposure, 
indicating that PAMAM dendrimer nanoparticles can penetrate into neurospheres 
through superficial cells. TFPI2, IGFBP3, and EGR1 were commonly responsive 
among specific pathways and show as key nodes in network analysis, suggesting that 
the restrained expression of TFPI2, IGFBP3, and EGR1 plays a very important role 
after exposure to PAMAM dendrimers and that these genes may be related to cell 
migration during neurodevelopment of neurospheres. 
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It is important to understand the drug delivery system of dendrimers in the 
human body. The biodistribution of PAMAM dendrimers has been studied in mice 
and rabbits. The present study simulated human tissue development using a 3-D 
culture system to study the biodistribution of dendrimers, using dendrimer-Alexa 
conjugates to track PAMAM dendrimers after exposure to neurospheres. PAMAM 
dendrimers were only observed on the surface of neurospheres during the initial 24 h 
of exposure; however, conjugates were observed in neurospheres after 2 days of 
exposure. These finding indicates that PAMAM dendrimer nanoparticles can 
penetrate into neurospheres through superficial cells. 
Neurospheres were allowed to differentiate for additional 5 days in NDM and 
neurite extension and differentiation was studied because they play a very important 
role during neurodevelopment. PAMAM-SC did not affect neurospheres at any test 
concentration. PAMAM-NH2 significantly inhibited neurosphere flare areas which 
indicate as cell migration and perforation at concentration of 1 μg/ml, 3 μg/ml and 10 
μg/ml. PAMAM-NH2 did not inhibit neurite length per cell at any concentration tested 
in the present study. In contrast, neurite length per cell significantly increased at 
concentration of 10 μg/ml, and this may be because of the PAMAM-induced decrease 
in the number of live cells. Cell proliferation assay was performed respectively using 
NEM after PAMAM exposure. Neurosphere proliferation and migration was inhibited 
for PAMAM-NH2 at concentration of 1μg/ml, 3 μg/ml and 10 μg/ml. To confirm the 
inhibit effect on cell proliferation, high magnification images (10x) was acquired. 
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Proliferation of cells in the flare areas which is shifted from the neurosphere core was 
investigated. The EdU positive cells significantly decreased in flare area, suggest that 
PAMAM dendrimer inhibit migration but also cell proliferation at concentration of 
1μg/ml. These results suggested that PAMAM may inhibited cell viability through 
proliferation and cell migration. However, after PAMAM exposure on neurosphere, 
no persistent effect on neurite extension of neurosphere, suggested that PAMAM 
dendrimer do not have specific development neurotoxicity. 
Microarray analysis after PAMAM exposure showed a down regulation of EGR1, 
which plays an important role in regulating cell proliferation and differentiation. 
Overexpression of EGR1 can induce the osteogenic differentiation of dental stem cells 
by regulating the expression of DLX3 and BMP2. Egr1 is one of the key transcription 
factors in extremely low-frequency electromagnetic field (ELF-EMF)-induced 
neuronal differentiation. The observed down regulation of EGR1 in the present study 
may be due to the positive charge of PAMAM dendrimer-NH2, which may influence 
ELF-EMF and induce neuronal migrations. SPRY1 may contribute to congenital 
disorders involving tissues of neural crest origin. Down regulation of SPRY1 revealed 
that PAMAM dendrimer exposure during fetal brain development may lead to 
congenital disorders. Overexpression of CYP26A1 induces neurodegenerative diseases 
by the enhancement of retinoic acid (RA) metabolites. Cationic PAMAM induces the 
overexpression of CYP26A1, which is considered as a potential risk for inducing some 
neural toxicity in the human brain. The observed down regulation of genes mostly 
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related to direct interactions and network targets and regulators pathways has revealed 
that PAMAM dendrimers affect regulator function through a direct interaction. Genes 
with similar functions usually fall into the same functional modules. The revealed 
genes were checked whether they are connected with each other using a 
bioinformatics approach. EGR1, TFPI2，IGFBP3, and ADM  were found to be the 
key node in their respective networks. The expressions of these genes were then 
checked by RT-PCR, most of the genes were down regulated. It was suggested 
that  the positive charge of PAMAM dendrimer-NH2 may influence ELF-EMF and 
inhibit neuronal proliferation, lead to congenital disorders. 
In conclusion, exposure of neurosphere to 1, 3, or 10 µg/ml concentrations of 
PAMAM dendrimers resulted in a reduced number of MAP2-positive cells but not 
neurite length/cells, indicating an inhibitory effect on neuronal migration but not 
differentiation. PAMAM dendrimer nanoparticles can penetrate into neurospheres 
through superficial cells. Microarray gene pathway analyses revealed a regulation of 
various genes for G4-PAMAM dendrimers, these genes are involved in various signal 
transduction pathways, and direct interactions and network pathways are the most 
related. Network analysis using the bioinformatics approach revealed that TFPI2, 
IGFBP3, and EGR1 play a very important role after exposure to PAMAM dendrimers. 
These findings suggest that the exposure of pre-differentiated cells to PAMAM 
dendrimers results in a change in cell migrations through TFPI2, IGFBP3, and EGR1 
regulated pathways. The biodistrubution and DNT of PAMAM dendrimer was  
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assessed, use of PAMAM-NH2 as drug carrier may induce adverse reactions on 
neurons. 
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Fig. 3-1 Experimental time schedules of PAMAM exposure, proliferation and 
differentiation (A). Gene expression analysis was conducted using total RNAs from 
neurospheres on day 5, followed by proliferation assay on day 5 to day 8. 
Morphological photographs for proliferation and differentiation of hNPCs in the 
neurosphere assay (B–F). 
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Fig. 3-2 Distribution images of PAMAM-NH2 dendrimers using a confocal laser 
microscope. 2-D photographs of sphere cross section (A, B, C) and 3-D images (D, E, 
F) were acquired at day 3 (A, D)，day 4 (B, E) and day 5 (C, F) time points after 
starting the sphere formation. 3-D images (D, E, F) were located from the top of 
sphere to center, they were reversed images and their thickness were 30 m. 
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 Fig. 3-3 Effects of PAMAM dendrimer on migration and proliferation of 
neurosphere. Representative images were acquired at day 8 PAMAM-NH2 treatment 
at concentrations of 1, 3 or 10 μg/ml for 72 h. Nuclei were stained with Hoechst 
33342 (A,D,G,J), newly generated cells from day 7 to day 8 was labeled by EDU 
(Alexa 555 fluorescence) (B,E,H,K).  
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Fig. 3-4 Quantified data on the effects on proliferation and migration of 
PAMAM-NH2 were acquired using Image J for measurement of sphere area. Data are 
expressed as the percentage of the control ± SD for four independent experiments. * P 
< 0.05, **P < 0.01, and ***P < 0.001 were considered to be statistically significant 
differences between the treatment group and the vehicle control. 
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Fig. 3-5 Effects of PAMAM dendrimer on migration and differentiation of 
neurosphere. Representative images were acquired without PAMAM treatment 
(vehicle control) or after 72 h of PAMAM G4-NH2 (A-C), PAMAM-SC (D-F) or 
Alexa488-labeled PAMAM-NH2 (G-I) treatment at concentrations of 3 or 10 μg/ml.  
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Fig. 3-6 Quantified data on the effects on migration of PAMAM-NH2 were acquired 
using Image J ver4 for measurement of sphere area and flare area. Data are expressed 
as the percentage of the control ± SD for four independent experiments. * P < 0.05, 
**P < 0.01, and ***P < 0.001 were considered to be statistically significant 
differences between the treatment group and the vehicle control. 
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Fig. 3-7 Photographs and quantified data of neurite length and nuclei number after 
PAMAM-NH2 treatment were measured using the In cell analyzer 1000. Morphology 
of neuronal cells at the 10x magnification of optical lens was acquired. 
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Fig. 3-8 Neurite lengths (A) and nuclei number (B) were measured. Data are 
expressed as the percentage of the control ± SD for three independent experiments. *P 
< 0.05, **P < 0.01, and ***P < 0.001 were considered to be statistically significant 
differences between the treatment group and the vehicle control. 
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 Fig. 3-9 Network analysis of genes with more than 1.5-fold changes selected from 
microarray analysis. Matched gene entities from the top five pathways as shown in 
Table 2 were then analyzed using natural language processing (NLP) network 
analyses from GeneSpring to find expanded interactions for EGR1 (A). 
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 Fig. 3-9 Analyzed using natural language processing (NLP) network analyses from 
GeneSpring to find expanded interactions for GFBP3 (B).  
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Fig. 3-9 Analyzed using natural language processing (NLP) network analyses from 
GeneSpring to find expanded interactions for TFPI2 and ADM (C).  
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Fig. 3-10 Expression of selected genes was analyzed by RT-PCR. Results of PAMAM 
treatment groups were related to controls set to one. * P < 0.05, **P < 0.01, and ***P 
< 0.001 were considered to be statistically significant differences between the 
treatment group and the vehicle control. 
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Table 3-1. Functional annotation pathway listed by pathway analysis. 
  
Functional annotated pathways  P-value 
Matched 
gene 
entities 
Gene entities 
in the 
pathway 
Direct Interactions 
 
4.1E-10 8 371 
Network Targets and Regulators 
 
1.7E-08 8 407 
Hs_Adipogenesis_WP236_44941 
 
0.0043 2 131 
Hs_Myometrial_Relaxation_and_Contr
action_Pathways_WP289_45373 
 
0.0060 2 156 
Hs_Regulation_of_Insulin-like_Growth
_Factor_(IGF)_Activity_by_Insulin-like
_Growth_Factor_Binding_Proteins_(IG
FBPs)_WP1899_45051 
0.0074 1 10 
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Table 3-2. Pathway analyses after PAMAM dendrimer exposure. Gene 
expression was shown as the log fold change referring to the control level. Genes 
which responses in repeated pathways were highlighted. 
 
Direct Interactions 
Genes Log2 FC in array1 Log2 FC in array 2 
KCNJ2 −2.6087 −2.0524 
TFPI2 −2.5823 −2.0296 
EGR1 −2.5140 −2.5834 
FAM150B −1.7865 −1.2568 
SPRY1 −1.4594 −1.7948 
PIP5K1B −1.4113 −1.5038 
SPRY4 −1.3292 −0.6029 
CDH6 −0.8651 −1.0540 
Network Targets and Regulators 
Genes Log2 FC in array 1 Log2 FC in array 2 
KCNJ2 −2.6087 −2.0524 
TFPI2 −2.5824 −2.0296 
FAM150B −1.7865 −1.2568 
SPRY −1.4594 −1.7948 
PIP5K1B −1.4113 −1.5038 
SPRY4 −1.3292 −0.6029 
CDH6 −0.8651 −1.0540 
KCNJ2 −2.6087 −2.0524 
 
Hs_Adipogenesis_WP236_44941 
Genes Log2 FC in array 1 Log2 FC in array 2 
CYP26A1 1.3427 1.5846 
EGR2 −1.2301 −1.3729 
   
Hs_Myometrial_Relaxation_and_Contraction_Pathways_WP289_45373 
Genes Log2 FC in array 1 Log2 FC in array 2 
ADM −2.9762 −2.2459 
IGFBP3 −2.7287 −2.1465 
Hs_Regulation_of_Insulin-like_Growth_Factor_(IGF)_Activity_by_Insulin-like_Gr
owth_Factor_Binding_Proteins_(IGFBPs)_WP1899_45051 
Genes Log2 FC in array 1 Log2 FC in array 2 
IGFBP3 −2.7287 −2.146 
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Chapter 4 Conclusions and future research 
4.1 Conclusions in chapter 2 
In chapter 2, a DNT test system was established using hNPCs and it was found 
that: 
1. Intact LM511 substrates are qualitatively important for efficient and stable 
hNPCs differentiation. The addition of poly-L-ornithine is advantageous for 
hNPCs proliferation, but not suitable for stable hNPCs differentiation. 
2. Benzo[a]pyrene and 5-Azacytidine were applied to the established system. 
Both chemicals significantly inhibited cell migration and induced apoptosis.  
3. The established LM511 culture system can distinguish between neurotoxic 
and non-neurotoxic substances, and it is suggested that this novel model is a 
good tool for investigations of environmental neurotoxicity. 
4.2 Conclusions in chapter 3 
It was then assessed the developmental neurotoxicity of PAMAM using the 
established system. It was identified that: 
1. A reduced number of MAP2-positive cells but not neurite length/cells after 
G4-PAMAM-NH2 dendrimers treatment, indicating an inhibitory effect on 
neuronal migration but not differentiation. 
2. PAMAM-NH2 dendrimer nanoparticles can penetrate into neurospheres 
through superficial cells on it.  
3. Network analysis showed three connected networks of the selected gene 
targets in direct interactions, Network targets and regulators, adipogenesis, 
myometrial relaxation/contraction, and insulin-like growth factor signaling.  
4. Egr1, IGFBP3, TFPI2, ADM were the key genes in each network, and the 
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expression of these genes was significantly downregulated.  
5. The biodistrubution and DNT of PAMAM dendrimer was fully assessed, use 
of PAMAM-NH2 as drug carrier may induce adverse reactions on neurons. 
 
4.3 Conclusions of this thesis 
 
An efficient and stable culture system for DNT assessment was established using 
LM511 BM. Further, It was found that PAMAM-SC did not affect neurospheres 
at any test concentration. PAMAM-NH2 can penetrate into neurospheres time 
dependently. Network analysis using the bioinformatics approach revealed that 
TFPI2, IGFBP3, and EGR1 play a very important role after exposure to 
PAMAM dendrimers. Cell proliferation and cell migration was significantly 
inhibited at concentration of 3 μg/ml and 10 μg/ml. However, after PAMAM 
exposure on neurosphere, no persistent effect on neurite extension of 
neurosphere. These findings suggest that the exposure of neurosphere to 
PAMAM dendrimers results in a change in cell proliferation and cell migrations 
through TFPI2, IGFBP3, and EGR1 regulated pathways. The biodistrubution and 
DNT of PAMAM dendrimer was fully assessed, use of PAMAM-NH2 as drug 
carrier may induce adverse reactions on neurons. 
 
 
 62 
 
4.4 Future work 
1. The mechanism of PAMAM-NH2 dendrimer induced developmental 
neurotoxicity will be studied. An enzyme activity assay and western blot analysis 
will be carry out to analysis PAMAM-NH2 induced DNT. The cellular ROS 
needed to be detect after exposure. 
2. The nontoxic PAMAM-SC should be assessed to find weather it can be used as 
drug carrier. A high concentration exposure assay and a gene expression profiling 
assay will be carried out to confirm the safety of PAMAM-SC.  
3. Using the novel established culture system, neurotoxicity of other chemicals or 
nanoparticles will be assessed. DNT of PAMAM-NH2 from generation 1 to 
generation 10 will be assessed using neurosphere. 
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